INTERVIEWThe head-in-the-sand approach stops herePharmaTimes Magazine talks to the new ABPI president Jonathan Emms about speaking out on behalf of patients
GENOMICSBusting the niche: the future of genomicsThe challenge is for pharma to adapt and start developing more specialised drugs
REAL-WORLD DATAGet realWhat does pharma need to know about putting real-world data into practice?
COUNTRY FOCUSNuts about Brazil? Does the Latin American country still retain the same allure it once did for life sciences?
PATIENT ENGAGEMENTWhen delivering treatment is not enoughHow can patients be encouraged to participate in their own care?
HEALTH FOCUSSticking with statinsSaviour or side-effect nightmare?
PATIENT FILES“Listening to patients is critical”How insight into living with a rare disease can help improve healthcare
No results were found
Get the latest pharma news delivered to your inbox
Car, Bonus and Excellent Benefits
£40000 - £44000 per annum Excellent Bonus, Car and Benefits
£26000 - £28000 per annum Excellent Bonus, Car and Benefits
Excellent Bonus, Car and Benefits
£50000 - £60000 per annum Excellent Bonus, Car and Benefits
Competitive Salary Bonus
What job are you looking for?
Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.